Phase 2b randomized, double-blind, parallel-group, placebo-controlled study of MAR001 in patients with elevated triglycerides and remnant cholesterol (TYDAL-TIMI 78) (NCT07028749)

Please login or create a FREE account to view this content

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo